Regulatory News:
The prospectus regarding Elekta’s (STO:EKTAB) rights issue of
convertible bonds has been approved and registered by the Swedish
Financial Supervisory Authority. The prospectus is now available on
Elekta’s website www.elekta.com
at the link ir.elekta.com and on SEB Enskilda’s website www.sebgroup.com/prospectuses (http://merchantbanking.sebgroup.com/prospectuses-and-downloads/prospectuses/).
The prospectus or the brochure will, subject to certain exceptions, be
distributed by mail to shareholders in Elekta. (http://ir.elekta.com/)
Invitation to subscribe for convertible bonds in Elekta AB (publ) (http://ir.elekta.com/)
(link to prospectus)
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial
Instruments Trading Act. The information was published at 11:00 CET on
April 5, 2012.
About Elekta
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy, radiosurgery and brachytherapy, as well
as workflow enhancing software systems across the spectrum of cancer
care.
Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide. Elekta employs around 3,300 employees
globally. The corporate headquarters is located in Stockholm, Sweden,
and the company is listed on the Nordic Exchange under the ticker EKTAb.
IMPORTANT NOTICE
These materials are not an offer of securities for sale in the United
States. Securities may not be offered or sold in the United States
absent registration or an exemption from registration under the United
States Securities Act of 1933, as amended (the "Securities Act”). The
securities to which these materials relate have not been and will not be
registered under the Securities Act and there will be no public offering
of the securities in the United States.
No offer or invitation to acquire securities of Elekta AB (publ) is
being made by or in connection with this release. Any such offer will be
made solely by means of the prospectus that Elekta AB (publ) will
prepare: (i) once it has been approved by the Swedish Financial
Supervisory Authority (Sw. Finansinspektionen) in accordance with the
Swedish Financial Instruments Trading Act and the Directive 2003/71/EC;
and (ii) published in accordance with Swedish law, together with its
English translation, (each as supplemented or amended), to, in each
case, the persons entitled to receive and rely upon such documents in
accordance with their respective terms.
This communication is directed in the United Kingdom solely to persons
who: (i) have professional experience in matters relating to investments
and who fall within the meaning of Article 19(5) of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 (the
"Order”); or (ii) are high net worth entities falling within Article
49(2)(a) to (d) of the Order and other persons to whom such
communication may otherwise lawfully be made (all such persons together
being referred to as the "Relevant Persons”). This communication must
not be acted on or relied on by persons who are not the Relevant
Persons. Any investment or investment activity to which this
communication relates is available only to the Relevant Persons and will
be engaged in only with the Relevant Persons. Persons distributing this
communication must satisfy themselves that it is lawful to do so.
Deutsche Bank AG is authorised under German Banking Law (competent
authority: BaFin – Federal Financial Supervisory Authority) and
authorised and subject to limited regulation by the Financial Services
Authority. Details about the extent of Deutsche Bank AG’s authorisation
and regulation by the Financial Services Authority are available on
request.
This information was brought to you by Cision http://www.cisionwire.com
